Medical Park Gaziosmanpasa Hospital

Merkez Mahallesi Çukurçeşme Cad. No: 57-59 Gaziosmanpaşa - İstanbul, Turkey

Total review: 2

Est.

Prostate Cancer Treatment

Starting from Price on request

Medical Park Gaziosmanpasa Hospital

Merkez Mahallesi Çukurçeşme Cad. No: 57-59 Gaziosmanpaşa - İstanbul, Turkey

Total review: 2

Established

Highlights at Medical Park Gaziosmanpasa Hospital

Map View

Click to explore
Reviews (2)

5.0
Accreditations
Languages spoken
- Arabic
- English
- French
- Georgian
- German

Prostate Cancer Treatment at Medical Park Gaziosmanpasa Hospital

Medical Park Gaziosmanpasa Hospital, can be found in Gaziosmanpasa, Istanbul, Turkey and offers its patients Prostate Cancer Treatment procedures as well as 125 other procedures, across 21 different procedure categories

. At present, there is no pricing information for Prostate Cancer Treatment procedures at Medical Park Gaziosmanpasa Hospital. The pricing information is quite specialised, so it's only available on request, and the average price is around $3,813.

Many medical professionals work at the Hospital, with 16 in total, and Medical Park Gaziosmanpasa Hospital is accredited by just one known accreditations institute, JCI Accredited

Facility Services Available at Medical Park Gaziosmanpasa Hospital

Airport pickup

Family accommodation

Free Wifi

Health insurance coordination

Hotel booking

Interpreter services

Local transportation booking

Parking available

Pharmacy

Phone in the room

Private rooms for patients available

Rehabilitation

Religious facilities

Restaurant

Special dietary requests accepted

Translation services

TV in the room

WHY US?

At Medijump, we're making medical easy. You can search, compare, discuss, and book your medical all in one place. We open the door to the best medical providers worldwide, saving you time and energy along the way, and it's all for FREE, no hidden fees, and no price markups guaranteed. So what are you waiting for?

Free

Best Price

Widest Selection

Risk-Free

What you need to know about Prostate Cancer Treatment in Istanbul

The core approach for Prostate Cancer Treatment incorporates a meticulous diagnostic process. This entails detailed examination to ascertain the disease's stage, tumor's size and location, patient's overall health status, and potential hazard of different treatment alternatives. Following this, a tailored treatment strategy is crafted, considering the patient's wishes and anticipated possible reactions and results. This individualized angle to treatment significantly impacts making therapies more effective and improving patient comfort and welfare throughout their pathway to healing.

There is no single prostate cancer treatment that can be used for everyone. The main treatment for prostate cancer includes surgery, radiation, chemotherapy, and immunotherapy.

What's the Recovery Time for Prostate Cancer Treatment Procedures in Istanbul?

The recovery time following a Prostate Cancer Treatment process can differ greatly from one person to the next. Variations in factors like the form and progression of prostate cancer, the particular treatment approach applied, and the person's entire health status can substantially affect recuperation durations. For example, recuperation durations typically extend further following operations such as a radical prostatectomy compared to therapies like radiotherapy.

Generally, after prostate cancer surgery, most men will get back to normal within six to eight weeks, but you may be able to go back to work within 3-4 weeks. After any type of therapy, you should be able to return to work the next day or if there are no symptoms that interfere with your ability to work. Make sure to ask your doctor how long until you can resume your normal activities, including exercises and heavy lifting.

What's the Success Rate of Prostate Cancer Treatment Procedures in Istanbul?

Survival rates are particularly high for patients diagnosed in the early stages of prostate cancer. The 5-year survival rate is nearly 100%, but if the prostate cancer has spread to other parts of the body, the survival rate is significantly reduced to 30%. Notwithstanding, it is crucial to bear in mind that such statistics represent mean values, and individual results can deviate significantly owing to numerous variables. These include the patient's general well-being, the cancer's progress, and the distinct therapy employed.